YHV-18789-81985
4 vaccinations
6 coded responses
43 check-ins
5 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 013 / MA
- Registered
- 2021-03-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-23
Registered in v-safe
-
2021-03-23
Dose 1 — Pfizer-BioNTech
- 2021-03-23
-
2021-03-24
Survey response — days 1–6 daily, dose 1MedDRA: Pre-existing disease — Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: lupusMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-25
- 2021-03-26
- 2021-03-27
- 2021-03-28
- 2021-03-29
- 2021-03-30
- 2021-04-06
-
2021-04-14
Dose 2 — Pfizer-BioNTech
- 2021-04-14
- 2021-04-14
-
2021-04-15
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-16
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness · Be unable to workAdult check-in
- 2021-04-17
- 2021-04-18
- 2021-04-20
- 2021-04-23
- 2021-04-28
- 2021-05-05
- 2021-05-12
- 2021-05-20
- 2021-05-27
-
2021-07-14
Survey response — 3 months, dose 2MedDRA: Nasopharyngitis, SARS-CoV-2 test negative — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: caught a common cold. Neg covid test.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-14
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
-
2021-07-23
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2021-08-19
Dose 3 — Pfizer-BioNTech
-
2021-08-19
Survey response — day 0, dose 3MedDRA: Dysgeusia, Immediate post-injection reaction — Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessFree text: metallic taste immediately after vaccineMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-20
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-08-21
-
2021-08-23
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-08-24
- 2021-08-25
- 2021-08-26
-
2021-09-02
Survey response — day 14, dose 3MedDRA: Pre-existing disease — Feeling: Poor · Be unable to work or attend school, Get care from a doctor or other healthcare professional · HospitalizationFree text: pneumothorax related to autoimmune diseaseMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-09-02
Report sent to call center — day 14, dose 3Be unable to work or attend school · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-09-08
Call successfulCompleted over the phone
- 2021-09-10
- 2021-09-16
- 2021-09-23
- 2021-09-30
- 2021-11-18
- 2022-02-17
-
2022-04-28
Dose 4 — Pfizer-BioNTechCo-administered: Shingles
- 2022-06-01
- 2022-06-04
- 2022-06-09
- 2022-07-28
-
2022-10-27
Survey response — 6 months, dose 4MedDRA: Pregnancy — Feeling: GoodFree text: pregnancyMedDRA releases: 2024-11 · check-in free text available
-
2023-04-28
Survey response — 12 months, dose 4MedDRA: Delivery, Hospitalisation, Parainfluenzae virus infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationMedDRA releases: 2024-11
-
2023-04-28
Report sent to call center — 12 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prHospitalization · 1 call case(s)
- 2023-05-01
-
2023-05-10
Call successfulCompleted over the phone
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-23 | Pfizer-BioNTech | |
| 2 | 2021-04-14 | Pfizer-BioNTech | |
| 3 | 2021-08-19 | Pfizer-BioNTech | No |
| 4 | 2022-04-28 | Pfizer-BioNTech | Shingles |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-07-14 | Successful 2021-07-23 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
| 2021-09-02 | Successful 2021-09-08 |
Completed over the phone |
| 2023-04-28 | Successful 2023-05-10 |
Completed over the phone |
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): lupus
Release 9 — 3 months, dose 2
Symptoms: caught a common cold. Neg covid test.
Release 9 — day 0, dose 3
Systemic reaction (other): metallic taste immediately after vaccine
Release 9 — day 14, dose 3
Symptoms: pneumothorax related to autoimmune disease
Release 12 — 6 months, dose 4
Symptoms: pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Delivery | · | · | ✓ |
| SD | Hospitalisation | · | · | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Parainfluenzae virus infection | · | · | ✓ |
| SD | Pre-existing disease | ✓ | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | SARS-CoV-2 test negative | ✓ | ✓ | ✓ |
| SRO | Dysgeusia | ✓ | · | ✓ |
| SRO | Immediate post-injection reaction | ✓ | · | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release